EP1251863A4 - 22 sezernierte humane proteine - Google Patents

22 sezernierte humane proteine

Info

Publication number
EP1251863A4
EP1251863A4 EP01910340A EP01910340A EP1251863A4 EP 1251863 A4 EP1251863 A4 EP 1251863A4 EP 01910340 A EP01910340 A EP 01910340A EP 01910340 A EP01910340 A EP 01910340A EP 1251863 A4 EP1251863 A4 EP 1251863A4
Authority
EP
European Patent Office
Prior art keywords
secreted proteins
human secreted
human
proteins
secreted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01910340A
Other languages
English (en)
French (fr)
Other versions
EP1251863A1 (de
Inventor
Craig A Rosen
George A Komatsoulis
Kevin P Baker
Charles E Birse
Daniel R Soppet
Henrik S Olsen
Paul A Moore
Ping Wei
Reinhard Ebner
D Roxanne Duan
Yanggu Shi
Gil H Choi
Michele Fiscella
Jian Ni
Steven M Ruben
Steven C Barash
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP1251863A1 publication Critical patent/EP1251863A1/de
Publication of EP1251863A4 publication Critical patent/EP1251863A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
EP01910340A 2000-01-31 2001-01-17 22 sezernierte humane proteine Withdrawn EP1251863A4 (de)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US17906500P 2000-01-31 2000-01-31
US179065P 2000-01-31
US18062800P 2000-02-04 2000-02-04
US180628P 2000-02-04
US22627900P 2000-08-18 2000-08-18
US226279P 2000-08-18
US25198800P 2000-12-05 2000-12-05
US251988P 2000-12-05
US25967801P 2001-01-05 2001-01-05
US259678P 2001-01-05
PCT/US2001/001434 WO2001054708A1 (en) 2000-01-31 2001-01-17 22 human secreted proteins

Publications (2)

Publication Number Publication Date
EP1251863A1 EP1251863A1 (de) 2002-10-30
EP1251863A4 true EP1251863A4 (de) 2005-03-02

Family

ID=27539005

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01910340A Withdrawn EP1251863A4 (de) 2000-01-31 2001-01-17 22 sezernierte humane proteine

Country Status (4)

Country Link
EP (1) EP1251863A4 (de)
AU (1) AU2001237958A1 (de)
CA (1) CA2396719A1 (de)
WO (1) WO2001054708A1 (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030149237A1 (en) * 2000-06-27 2003-08-07 Corine Vernet Novel polynucleotides and polypeptides encoded thereby
US7981420B2 (en) * 2000-12-22 2011-07-19 Max-Planck-Gesellschaft Zur Foederung Der Wissenschaften E.V. Therapeutic use of antibodies directed against repulsive guidance molecule (RGM)
DE60129848T2 (de) * 2000-12-28 2008-04-24 Shionogi & Co., Ltd. Chordin-ähnliche polypeptide und deren dns
US7125663B2 (en) 2001-06-13 2006-10-24 Millenium Pharmaceuticals, Inc. Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
JP2003245084A (ja) 2001-12-20 2003-09-02 Morinaga Milk Ind Co Ltd 脳梁又は精子の形成不全の診断及び治療に有用な新規遺伝子、並びにその用途
WO2003089608A2 (en) 2002-04-18 2003-10-30 The General Hospital Corporation Drg11-responsive (dragon) gene family
AU2003271579A1 (en) * 2002-09-02 2004-03-19 Develogen Aktiengesellschaft Fur Entwicklungsbiologische Forschung Proteins involved in the regulation of energy homeostasis
DE10254601A1 (de) * 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
AU2015242979B2 (en) * 2002-11-22 2016-12-01 Ganymed Pharmaceuticals Ag Genetic products differentially expressed in tumors and the use thereof
AU2013260709C1 (en) * 2004-05-18 2016-09-08 Astellas Pharma Inc. Genetic products differentially expressed in tumors and the use thereof
DE102004024617A1 (de) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung
ES2547866T3 (es) 2005-02-16 2015-10-09 The General Hospital Corporation Uso de proteínas de fusión de hemojuvelina para regular el metabolismo del hierro mediado por hepcidina
JP2009510002A (ja) 2005-09-30 2009-03-12 アボット ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディトゲゼルシャフト 反発誘導分子（ｒｇｍ）タンパク質ファミリーのタンパク質の結合ドメイン、及びその機能的断片、及びそれらの使用
EP1790664A1 (de) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoklonale Antikörper gegen Claudin-18 zur Behandlung von Krebs
US8895002B2 (en) 2007-04-09 2014-11-25 The General Hospital Corporation Hemojuvelin fusion proteins and uses thereof
US8962803B2 (en) 2008-02-29 2015-02-24 AbbVie Deutschland GmbH & Co. KG Antibodies against the RGM A protein and uses thereof
MX2012006560A (es) 2009-12-08 2012-10-05 Abbott Gmbh & Co Kg Anticuerpos monoclonales contra la proteina rgm a para utilizarse en el tratamiento de degeneracion de capa de fibra de nervio retinal.
PL2807192T3 (pl) 2012-01-27 2019-02-28 Abbvie Deutschland Kompozycja oraz sposób diagnostyki i leczenia chorób związanych ze zwyrodnieniem neurytów
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
WO2013174404A1 (en) 2012-05-23 2013-11-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
JP6499079B2 (ja) 2012-11-13 2019-04-10 バイオエヌテック アーゲーＢｉｏＮＴｅｃｈ ＡＧ クローディンを発現するガン疾患を処置するための剤
WO2014127785A1 (en) 2013-02-20 2014-08-28 Ganymed Pharmaceuticals Ag Combination therapy involving antibodies against claudin 18.2 for treatment of cancer
WO2014146672A1 (en) 2013-03-18 2014-09-25 Ganymed Pharmaceuticals Ag Therapy involving antibodies against claudin 18.2 for treatment of cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2000015659A2 (en) * 1998-09-16 2000-03-23 Zymogenetics, Inc. Stomach polypeptide zsig28

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2000015659A2 (en) * 1998-09-16 2000-03-23 Zymogenetics, Inc. Stomach polypeptide zsig28

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL 19 January 2000 (2000-01-19), "Homo sapiens Claudin-18 mRNA, compete cds", XP002296100, Database accession no. AF221069 *
MORITA K ET AL: "CLAUDIN MULTIGENE FAMILY ENCODING FOUR-TRANSMEMBRANE DOMAIN PROTEIN COMPONENTS OF TIGHT JUNCTION STRANDS", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE. WASHINGTON, US, vol. 96, January 1999 (1999-01-01), pages 511 - 516, XP002942697, ISSN: 0027-8424 *
See also references of WO0154708A1 *

Also Published As

Publication number Publication date
CA2396719A1 (en) 2001-08-02
EP1251863A1 (de) 2002-10-30
WO2001054708A1 (en) 2001-08-02
AU2001237958A1 (en) 2001-08-07

Similar Documents

Publication Publication Date Title
EP1181390A4 (de) 27 menschliche, sekretierte proteine
EP1251863A4 (de) 22 sezernierte humane proteine
EP1175438A4 (de) 62 humane sekretierte proteine
EP1175439A4 (de) 49 humane sekretierte proteine
EP1165827A4 (de) 45 humane sekretierte proteine
EP1159284A4 (de) 33 human sekrteierte proteine
EP1254242A4 (de) 17 humane sekretierte proteine
EP1368468A4 (de) Menschliche sezernierte proteine
EP1173477A4 (de) 49 humane sekretierte Proteine
EP1165602A4 (de) 49 menschliche, sekretierte proteine
EP1169332A4 (de) 49 human sekrtierte proteine
EP1144614A4 (de) Menschliche, ausgeschiedene proteine
EP1171460A4 (de) 48 menschliche sekretierte proteine
EP1370651A4 (de) 70 humane sekretierte proteines
EP1165828A4 (de) 50 menschliche sekretierte proteine
EP1317471A4 (de) 21 menschliche sekretierte proteine
EP1185285A4 (de) 49 humane sekretierte proteine
EP1322657A4 (de) 22 humane sezernierte proteine
EP1317472A4 (de) 17 menschliche sekretierte proteine
EP1171626A4 (de) 50 humane sekretierte proteine
EP1159287A4 (de) 50 menschliche sekretierte proteine
EP1165123A4 (de) 48 menschliche sekretierte proteine
EP1181303A4 (de) 50 human-ausgeschiedene proteine
EP1165591A4 (de) 47 menschliche sekretierte proteine
EP1322659A4 (de) 21 humane sezernierte proteine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20020812

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

RIC1 Information provided on ipc code assigned before grant

Ipc: 7C 07K 14/705 A

Ipc: 7A 61K 38/16 B

Ipc: 7C 12N 9/00 B

Ipc: 7A 61K 38/43 B

Ipc: 7G 01N 33/68 B

Ipc: 7G 01N 33/53 B

Ipc: 7A 61K 39/395 B

Ipc: 7A 61K 48/00 B

Ipc: 7C 12N 15/12 B

Ipc: 7C 07K 14/47 B

Ipc: 7A 61K 31/713 B

Ipc: 7C 12N 15/52 B

Ipc: 7C 12Q 1/68 B

Ipc: 7A 61K 31/7088 B

A4 Supplementary search report drawn up and despatched

Effective date: 20050117

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION HAS BEEN WITHDRAWN

18W Application withdrawn

Effective date: 20060303